Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2024年10月22日
	新闻
	Impact on Prognosis of Stage I Non–Small Cell Lung Cancer Secondary to Delays in ... RSNA Journals This allowed us to model the increase in tumor size for different diagnostic delays and estimate the decrease in the lung cancer cure rate based on ... 标记为不相关
	What is Early-Stage Non-Small Cell Lung Cancer? - Cure Today Cure Today Dr. Christopher Towe: You know, it's interesting, in my practice we're seeing more and more patients whose cancers are detected on lung cancer ... 标记为不相关
	Advice for Someone with Early-Stage Non-Small Cell Lung Cancer - Cure Today Cure Today A lung cancer diagnosis can be scary and overwhelming for both patients and their caregivers or loved ones. They may experience fear and shock. This ... 标记为不相关
	Impact of Bone Metastasis on Prognosis in Non-Small Cell Lung Cancer Patients Treated ... Frontiers Lung cancer is a leading cause of cancer-related deaths globally, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of ... 标记为不相关
	Previse Awarded $1.8M NIH Grant to Develop Esophageal Cancer Test | 360Dx 360Dx NeoGenomics Wins New York State Approval for Solid Tumor, Lung Cancer NGS Tests · Cizzle Biotechnology Inks Licensing Deal to Bring Lung Cancer ... 标记为不相关
	Avacta Therapeutics, Tempus Partner to Advance FAP-Based Peptide Drug Conjugates Precision Medicine Online Lung Cancer · Colorectal Cancer · Prostate Cancer · Ovarian Cancer ... NeoGenomics Wins New York State Approval for Solid Tumor, Lung Cancer NGS Tests ... 标记为不相关
	FDA grants de novo clearance to airway stent covered with human tissue - Fierce Biotech Fierce Biotech Related. Novocure nets FDA approval for Tumor Treating Fields in metastatic lung cancer. "We are optimistic that the AMStent system will prove to be ... 标记为不相关
	Exciting Developments and Novel Targets in Chronic Lymphocytic Leukemia Treatment HMP Global Learning Network Hepatocellular Carcinoma · Lung Cancer · Mantle Cell Lymphoma · Multiple Myeloma · Non-Small-Cell Lung Cancer · Prostate Cancer. Advertisement. 标记为不相关
	Zymeworks doses first subject in Phase I trial of ZW171 for various forms of cancer Clinical Trials Arena Zymeworks has dosed the first subject in a Phase I trial of ZW171 to treat ovarian cancer, non-small cell lung cancer and other cancers. 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈